Cancer is a long-standing disease, and the use of anticancer
drugs
can cause many different harmful side effects. Therefore, the quantitative
analysis of anticancer drugs is crucial. Among all the analytical
techniques that have been utilized for the detection of doxorubicin,
electrochemical sensors have drawn exceptional consideration because
they are simple, affordable, and highly sensitive. Manganese tetraphenylporphyrin
decorated reduced graphene oxide (Mn-TPP/RGO), tetraphenylporphyrin
decorated reduced graphene oxide (TPP/RGO), and reduced graphene oxide
(RGO) nanostructure based glassy carbon electrodes (GCEs) were fabricated
for the detection of doxorubicin (DOX). The synthesized materials
were characterized by FTIR, scanning electron microscopy (SEM), ultraviolet–visible
spectroscopy (UV/vis), energy dispersive X-ray spectroscopy (EDS),
and X-ray diffraction (XRD). Doxorubicin detection was performed using
differential pulse voltammetry (DPV), electrochemical impedance spectroscopy
(EIS), and cyclic voltammetry (CV). Among the prepared electrodes,
Mn-TPP/RGO modified GCE gave an optimum peak current at pH 3. The
Mn-TPP/RGO modified electrode showed significant linear response range
(0.1–0.6 mM); effective sensitivity (112.09 μA mM–1 cm–2); low detection limit (63.5
μM); and excellent stability, selectivity, repeatability, and
reproducibility toward doxorubicin. With differential pulse voltammetry,
LoD and sensitivity were 27 μM and 0.174 μA μM–1 cm–2, respectively. Real sample
analysis was also performed in human serum, and it depicted reasonable
recovery results for spiked doxorubicin.